Jul 3, 26 · No. 083 · v1.83.0

New criteria for asthma comorbidity (c6) and untreated eosinophilic exacerbations (c7) plus refined double-therapy risk (c4) target patients needing earlier intervention.


Don't base your organization's health on a tiny sample size. Spot the billable details and safety risks buried in your records, ensuring you're paid for the care you provide.